A critical role of transcription factor YY1 in rheumatoid arthritis by regulation of interleukin-6

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text

Medicine, Internal Medicine, Clinical Classification Systems +13

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Estelle Bettelli, Yijun Carrier, Wenda Gao et al. · Nature · 2006 · 6.9K citations

Life Sciences, Developmental Biology, Immunology +16

Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee

Roy D. Altman, E. Asch, D. Blöch et al. · Arthritis & Rheumatism · 1986 · 6.8K citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Josef S Smolen, André Beaulieu, Andrea Rubbert‐Roth et al. · The Lancet · 2008 · 1.4K citations

Medicine, Immunology, Pharmacology +16

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Paul Emery, Edward Keystone, Hans‐Peter Tony et al. · Annals of the Rheumatic Diseases · 2008 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16